Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. BOLD.NASDAQ

Boundless Bio, Inc. Common Stock (BOLD NASDAQ) stock market data APIs

$3.82 0.11(3%) as of July 26, 2024
Price chart is built with Anychart

Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. The company was incorporated in 2018 and is headquartered in San Diego, California.

Boundless Bio, Inc. Common Stock Financial Data Overview

3.71
3.82
-
4.1181
3.62
3.4-15.24
301 M
22 239 K
0
-12.27
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BOLD',
Type: 'Common Stock',
Name: 'Boundless Bio, Inc. Common Stock',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00Q4W34T4',
ISIN: NULL,
CUSIP: NULL,
CIK: '1782303',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2024-03-28',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Boundless Bio, Inc. Common Stock Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -53 839 000
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Boundless Bio, Inc. Common Stock Earnings via APIs

  • Latest Release 2024-05-13
  • EPS/Forecast -0.55

Get Boundless Bio, Inc. Common Stock End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Boundless Bio, Inc. Common Stock latest news via APIs

Insiders are Amassing These 10 Stocks in April

In this article, we will take a detailed look at Insiders are Amassing These 10 Stocks in April. For a quick overview of such stocks, read our article Insiders are Amassing These 5 Stocks in April. ...

5AM Ventures Celebrates 20th FDA Product Approval Investing in Breakthrough Science

SAN FRANCISCO and BOSTON, March 23, 2023 (GLOBE NEWSWIRE) -- 5AM Ventures is pleased that the U.S. Food and Drug Administration (FDA) approved REZZAYO™ (rezafungin for injection) for the treatmen...
  • 5AM VENTURE MANAGEMENT
  • HEALTH
  • LLC
Do you have any questions?
support@eodhistoricaldata.com